Development and Validation for the Estimation of Assay and Forced Degradation Impurities of Goserelin Acetate Sustained-Release Implant Using HPLC and LC

Development and Validation for the Estimation of Assay and Forced Degradation Impurities of Goserelin Acetate Sustained-Release Implant Using HPLC and LC–MS

Published:2023-08-14 Issue:8-9 Volume:86 Page:595-603
ISSN:0009-5893
Container-title:Chromatographia
language:en
Short-container-title:Chromatographia

Author:

Huang Dan,Tian Yufei,Zheng Yili,Li Mengyu,Xu Xia,Chen Hongyuan,Rui Wen

Funder

The Special Fund for Science and Technology Development in 2017 Guangdong Province of South China

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,Clinical Biochemistry,Biochemistry,Analytical Chemistry

Link

https://link.springer.com/content/pdf/10.1007/s10337-023-04272-1.pdf

Reference30 articles.

1. Baum M (2001) A vision for the future? Br J Cancer 85:15–18. https://doi.org/10.1054/bjoc.2001.1984

2. Goldhirsch A, Glick JH, Gelber RD et al (2005) Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16:1569–1583. https://doi.org/10.1093/annonc/mdi326

3. Emens LA, Davidson NE (2003) Adjuvant hormonal therapy for premenopausal women with breast cancer. Clin Cancer Res 9:486S-S494

4. Eifel P, Axelson JA, Costa J et al (2001) National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1–3, 2000. J Natl Cancer Inst 93:979–989. https://doi.org/10.1093/jnci/93.13.979

5. Budäus L, Leyh-Bannurah S-R, Salomon G et al (2016) Initial experience of 68Ga-PSMA PET/CT imaging in high-risk prostate cancer patients prior to radical prostatectomy. Eur Urol 69:393–396. https://doi.org/10.1016/j.eururo.2015.06.010